Skip to main content
. 2008 Jan 22;7:8. doi: 10.1186/1476-4598-7-8

Figure 8.

Figure 8

Independent TaqMan® PCR validation of a set of selected genes from both cohorts in a test set of serous papillary adenocarcinomas of varying grade and stage. BTC and FGF2 provided the best distinction between recurrent and primary tumours with fold changes of 2.8 and 2.71 respectively.